1,409
Views
45
CrossRef citations to date
0
Altmetric
Review Articles

Gut indigenous microbiota and epigenetics

Article: 17195 | Received 10 Jan 2012, Accepted 29 Feb 2012, Published online: 28 Mar 2012

References

  • Feinberg AP. Epigenetics at the epicenter of modern medicine. JAMA. 2008; 299: 1345–50.
  • Furrow RE, Christiansen B, Feldman MW. Environment-sensitive epigenetics and the heritability of complex diseases. Genetics. 2011; 189: 1377–87.
  • Tollefsbol TO. Handbook of epigenetics: the new molecular and medical genetics. Academic Press: London, 2010; 618.
  • Choudhary C, Kumar C, Gnad F, Nielsen ML, Rehman M, Walther TC, et al. Lysine acetylation targets protein complexes and co-regulates major cellular functions. Science. 2009; 325: 834–40.
  • Casadesus J, Low D. Epigenetic gene regulation in the bacterial world. Microbiol Mol Biol Rev. 2006; 70: 830–56.
  • Martens JW, Margossian AL, Schmitt M, Foekens J, Harbeck N. DNA methylation as a biomarker in breast cancer. Future Oncol. 2009; 5: 1245–56.
  • Qureshi SA, Bashir MU, Yaqinuddin A. Utility of DNA methylation markers for diagnosing cancer. Int J Surg. 2010; 8: 194–8.
  • Tost J. DNA methylation: an introduction to the biology and the disease-associated changes of a promising biomarker. Mol Biotechnol. 2010; 44: 71–81.
  • Oka T, Sato H, Ouchida M, Utsunomiya A, Yoshino T. Cumulative epigenetic abnormalities in host genes with viral and microbial infection during initiation and progression of malignant lymphoma/leukemia. Cancers. 2011; 3: 568–81.
  • Paschos K, Allday MJ. Epigenetic reprogramming of host genes in viral and microbial pathogenesis. Trends Microbiol. 2010; 18: 439–47.
  • Gilbert SF, McDonald E, Boyle N, Buttino N, Gyi L, Mai M, et al. Symbiosis as a source of selectable epigenetic variation: taking the heat for the big guy. Phil Trans R Soc B. 2010; 365: 671–8.
  • Dumas ME, Barton RH, Toye A, Cloarec O, Blancher C, Rothwell A, et al. Metabolic profiling reveals a contribution of gut microbiota to fatty liver phenotype in insulin-resistant mice. Proc Natl Acad Sci USA. 2006; 103: 12511–16.
  • Shenderov BA. Functional foods in metabolic syndrome prophylaxis. Moscow: DeLi Print. 2008. p. 319. ( in Russian).
  • Csoka AB, Szyf M. Epigenetic side-effects of common pharmaceuticals: a potential new field in medicine and pharmacology. Med Hypotheses. 2009; 73: 770–80.
  • Hu S, Dong TS, Dalal SR, Wu F, Bissonnette M, Kwon JH, et al. The microbe-derived short chain fatty acid butyrate targets miRNA-dependent p21 gene expression in human colon cancer. PLoS ONE. 2011; 6: e16221. doi: 10.1371/journal.pone.0016221.
  • Martin F-PJ, Sprenger N, Montoliu I, Rezzi S, Kochhar S, Nicholson JK. Dietary modulation of gut functional ecology studied by fecal metabonomics. J Proteome Res. 2010; 9: 5284–95.
  • Phillips ML. Commensal bacteria damage host DNA. The Scientist. 10August, 2006. Available from http://classic.the-scientist.com/news/display/24285/.
  • Shenderov BA. Probiotic (symbiotic) bacterial languages. Anaerobe. 2011; 17: 490–5.
  • Holmes E, Li JV, Athanasiou T, Ashrafian H, Nicholson JK. Understanding the role of gut microbiome-host metabolic signal disruption in health and disease. Trends Microbiol. 2011; 19: 349–59.
  • Kinross JM, Darzi AW, Nicholson JK. Gut microbiome-host interactions in health and disease. Genome Medicine. 2011; 3: 14. 10.3402/mehd.v23i0.17195.
  • Shenderov BA. Probiotics and Functional Foods. 2011. In: Food Engineering, Encyclopedia of Life Support Systems (EOLSS). Developed under the auspices of the UNESCO, Eolss Publishers, Oxford, UK. Available from http:www.eolss.net [cited 19 September 2011]..
  • Shenderov BA. Modern condition and prospective host microecology investigations. Microb Ecol Health Dis. 2007; 19: 145–9.
  • Shenderov BA, Ivanova Ja V, Sorokina IM.2010. Composite additive. Patent RU 2397246 C1, 1-10 (In Russian).
  • Zamudio NM, Chong S, O'Bryan MK. Epigenetic regulation in male germ cells. Reproduction. 2008; 136: 131–46.
  • Stead LM, Brosnan JT, Brosnan ME, Vance DE, Jacobs RL. Is it time to reevaluate methyl balance in humans?. Am J Clin Nutr. 2006; 83: 5–10.
  • Bissinger E-M, Heinke R, Sippl W, Jung M. Targeting epigenetic modifiers: Inhibitors of histone methyltransferases. Med Chem Commun. 2010; 1: 114–124. doi: 10.1039/c0md00062k.
  • Kim GW, Gocevski G, Wu CJ, Yang XJ. Dietary, metabolic, and potentially environmental modulation of the lysine acetylation machinery. Int J Cell Biol. 2010; 632739.
  • Wang Q, Zhang Y, Yang C, Xiong H, Lin Y, Yao J, et al. Acetylation of Metabolic Enzymes Coordinates Carbon Source Utilization and Metabolic Flux. Science. 2010; 327: 1004–7.
  • Zhao S, Xu W, Jiang W, Yu W, Lin Y, Zhang T. Regulation of cellular metabolism by protein lysine acetylation. Science. 2010; 327: 1000–4.
  • Bestor TH, Verdin GL. DNA methyltransferases. Curr Opin Cell Biol. 1994; 259: 946–951.
  • Ishikawa K, Handa N, Sears L, Raleigh EA, Kobayashi I. Cleavage of a model DNA replication fork by a methyl-specific endonuclease. Nucl Acids Res. 2011; 39: 5489–98.
  • Bao B, Rodriguez-Melendez R, Wijeratne SSK, Zempleni J. Biotin Regulates the expression of holocarboxylase synthetase in the miR-539 pathway in HEK-293 Cells. J Nutr. 2010; 140: 1546–51.
  • Zempleni J. Uptake, localization, and non-carboxylase roles of biotin. Ann Rev Nutr. 2005; 25: 175–96.
  • Chew YC, West JT, Kratzer SJ, Ilvarsonn AM, Eissenberg JC, Dave BJ, et al. Biotinylation of histones represses transposable elements in human and mouse cells and cell lines, and in Drosophila melanogaster. J Nutrition. 2008; 138: 2316–22.
  • Kobza K, Sarath G, Zempleni J. Prokaryotic BirA ligase biotinylates K4, K9, K18 and K23 in histone H3. BMB reports. 2008; 41: 1–6.
  • Qiu S, Adema CM, Lane T. A computational study of off-target effects of RNA interference. Nucleic Acids Res. 2005; 33: 1834–47.
  • Wolfson M, Tacutu R, Budovsky A, Aizenberg N. Fraifeld VE. Common epigenetic mechanisms of aging and age-related diseases: the role for micro RNAs. The Problems of Aging and Longevity (Kiev). 2008; 17: 184–201.
  • Putral LN, Gu W, McMillan NA. RNA interference for the treatment of cancer. Drug News Perspect. 2006; 19: 317–24.
  • Craig SAS. Betaine in human nutrition. Am J Clin Nutr. 2004; 80: 539–49.
  • Rossi M, Amaretti A, Raimondi S. Folate Production by probiotic bacteria. Nutrients. 2011; 3: 118–34.
  • Spencer MD, Hamp TJ, Reid RW, Fisher LM. Zeisel SH, Fodor AA. Association between composition of the human gastrointestinal microbiome and development of fatty liver with choline deficiency. Gastroenterology. 2011 March; 140(3): 976–86.
  • Jacob RA. Folate, DNA methylation, and gene expression: factors of nature and nurture. Am J Clin Nutr. 2000; 72: 903–4.
  • Abell GCJ, Conlon MA, McOrist AL. Methanogenic archaea in adult human faecal samples are inversely related to butyrate concentration. Microb Ecol Health Dis. 2006; 18: 154–60.
  • Michalke K, Schmidt A, Huber B, Meyer J, Sulkowski M, Hirner A, et al. Role of intestinal microbiota in transformation of Bismuth and other metals and metalloids into volatile methyl and hydride derivatives in humans and mice. Appl Environ Microbiol. 2008; 74: 3069–75.
  • Gross G, Jacobs DM, Peters S, Possemiers S, van Duynhoven J, Vaughan EE, van de Wiele T. In vitro bioconversion of Polyphenols from black tea and red wine/ grape juice by human intestinal microbiota displays strong interindividual variability. J Agric Food Chem. 2010; 58: 10236–46.
  • Selma MV, Espin JC, Barberan T. Interaction between phenolics and gut microbiota: role in human health. J Agric Food Chem. 2009; 57: 6485–01.
  • Aoyama M, Kotani J, Usami M. Butyrate and propionate induced activated or non-activated neutrophil apoptosis via HDAC inhibitor activity but without activating GPR-41/GPR-43 pathways. Nutrition. 2010; 26: 653–61.
  • Dashwood RH, Myzak MC, Ho E. Dietary HDAC inhibitors: time to rethink weak ligands in cancer chemoprevention?. Carcinogenesis. 2006; 27: 344–9.
  • Rooks MG, Garrett S. Bacteria, food, and cancer. F1000 Biology Reports. 2011; 3: 12. 10.3402/mehd.v23i0.17195.
  • Waby JS, Chirakkal H, Yu C, Griffiths GJ, Benson RS, Bingle CD, et al. Sp1 acetylation is associated with loss of DNA binding at promoters associated with cell cycle arrest and cell death in a colon cell line. Mol Cancer. 2010; 9: 275. 10.3402/mehd.v23i0.17195.
  • Lawless MW, Norris S, O'Byme KJ, Gray SG. Targeting histone deacetylases for the treatment of disease. J. Cell Mol Medicine. 2009; 13: 826–52.
  • Cheng X, Horton JR, Yang Z, Kalman D, Zhang X, Hattman S, et al. 2010. Small Molecule inhibitors of Bacterial DAM DNA Methyltransferases. USA Patent 11/720971. A1. Available from http/:www.freepatentsonline.com/y2010/0035945.html.
  • Ma X, Ezzeldin HH, Diasio RB. Histone deacetlase inhibitors: current status and overview of recent clinical trials. Drugs. 2009; 69: 1911–34.
  • Ulrey CL, Liu L, Andrews LG, Tollefsbol TO. The impact of metabolism on DNA methylation. Hum Mol Genet. 2005 Apr 15; 14 Spec No 1: 139–47.